EvoPlexus Medics ApS: Financial statements 2025
CVR: 40782001
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
EvoPlexus Medics ApS (CVR 40782001) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -50,496 and a net result of DKK -50,498 compared with DKK -38,945 the year before. Equity in the 2025 report amounted to DKK -249,603.
- Gross Profit
- DKK -50,496
- Profit/Loss
- DKK -50,498
- Equity
- DKK -249,603
- Total Assets
- DKK 11,067
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -50 t. | -50 t. | -250 t. | - |
| 2024 | - | -39 t. | -39 t. | -199 t. | - |
| 2023 | - | -65 t. | -65 t. | -160 t. | - |
| 2022 | - | -78 t. | -78 t. | -95 t. | - |
| 2021 | - | -47 t. | -47 t. | -17 t. | 0 |
Official annual report
How creditworthy is EvoPlexus Medics ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
EvoPlexus Medics ApS has published its annual report for 2024. Gross profit came to DKK -38,731, and the net result was DKK -38,945.
About EvoPlexus Medics ApS
EvoPlexus Medics ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2019. The company is registered under the industry Computerprogrammering. The management consists of Serkawt Khola. The company is owned by EvoPlexus Holding ApS. According to the 2021 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -50,496 and a net result of DKK -50,498 compared with DKK -38,945 the year before. Equity in the 2025 report amounted to DKK -249,603.